Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Hypertension (Dallas, Tex. : 1979)
|
September 26, 2007
Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life
Douglas S Lee, Joseph M Massaro, Thomas J Wang, et al.
Circulation
|
December 1, 2004
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study
Mariya P Tokmakova, Hicham Skali, Satish Kenchaiah, et al.
Journal of the American College of Cardiology
|
May 28, 2021
Pericardial Fat and the Risk of Heart Failure
Satish Kenchaiah, Jingzhong Ding, J Jeffrey Carr, et al.
The American Journal of Cardiology
|
June 29, 2004
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)
Satish Kenchaiah, Marc A Pfeffer, Martin St John Sutton, et al.
American Heart Journal
|
August 17, 2004
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial
Satish Kenchaiah, Barry R Davis, Eugene Braunwald, et al.
The American Journal of Cardiology
|
January 29, 2013
Usefulness of biventricular volume as a predictor of mortality in patients with diabetes mellitus (from the Diabetes Heart Study)
Amanda J Cox, Christina E Hugenschmidt, Patty T Wang, et al.
Circulation
|
July 20, 2007
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Satish Kenchaiah, Stuart J Pocock, Duolao Wang, et al.
American Heart Journal
|
July 6, 2010
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)
Faisal Shamshad, Satish Kenchaiah, Peter V Finn, et al.
Journal of the American Heart Association
|
November 19, 2013
Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart Study
Susie N Hong, Philimon Gona, Joao D Fontes, et al.
American Heart Journal
|
July 11, 2006
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Rajesh Janardhanan, Satish Kenchaiah, Eric J Velazquez, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Hypertension (Dallas, Tex. : 1979)
|
September 26, 2007
Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life
Douglas S Lee, Joseph M Massaro, Thomas J Wang, et al.
Circulation
|
December 1, 2004
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study
Mariya P Tokmakova, Hicham Skali, Satish Kenchaiah, et al.
Journal of the American College of Cardiology
|
May 28, 2021
Pericardial Fat and the Risk of Heart Failure
Satish Kenchaiah, Jingzhong Ding, J Jeffrey Carr, et al.
The American Journal of Cardiology
|
June 29, 2004
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)
Satish Kenchaiah, Marc A Pfeffer, Martin St John Sutton, et al.
American Heart Journal
|
August 17, 2004
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial
Satish Kenchaiah, Barry R Davis, Eugene Braunwald, et al.
The American Journal of Cardiology
|
January 29, 2013
Usefulness of biventricular volume as a predictor of mortality in patients with diabetes mellitus (from the Diabetes Heart Study)
Amanda J Cox, Christina E Hugenschmidt, Patty T Wang, et al.
Circulation
|
July 20, 2007
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Satish Kenchaiah, Stuart J Pocock, Duolao Wang, et al.
American Heart Journal
|
July 6, 2010
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)
Faisal Shamshad, Satish Kenchaiah, Peter V Finn, et al.
Journal of the American Heart Association
|
November 19, 2013
Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart Study
Susie N Hong, Philimon Gona, Joao D Fontes, et al.
American Heart Journal
|
July 11, 2006
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Rajesh Janardhanan, Satish Kenchaiah, Eric J Velazquez, et al.
Page
of 3